Document is current
Any future updates will be listed below
-
Authors
Yao, Yunqi
Zhang, Lin
Cheng, Fuyi
Jiang, Qingyuan
Ye, Yixin
Ren, Yushuang
He, Yuting
Su, Dongsheng
Cheng, Lin
Shi, Gang
Dai, Lei
Deng, Hongxin https://orcid.org/0000-0002-8875-4493
-
Funding
Funding for this research was provided by:
National Key R&D Program of China grant (2017YFA0105702)
the technology Major Project in Sichuan Province of China (2022YFS0153)
the technology Major Project in Sichuan Province of China (2022ZDZX0024)
Sichuan Province Science and Technology Support Program (ZYGD20003)
- License Information
-
More Information
Article History
Received: 26 August 2022
Accepted: 17 July 2023
First Online: 27 July 2023
Declarations
:
: The umbilical cord tissue used in our study was obtained from healthy donors at the Sichuan Maternal and Child Health Hospital, following their consent according to procedures approved by the Medical Ethics Committee of Sichuan University. Our study adheres to the Declaration of Helsinki. (1) Title of the approved project: Preclinical study of mesenchymal stem cells. Full name of the institutional approval committee or unit: Medical Ethics Committee of Sichuan University, Chengdu, China. Approval number: No. K2018109-1. Date of approval: 14.12. 2018. The reporting of this study conforms to ARRIVE guidelines. All experimental animals were well cared for and were raised and handled strictly in accordance with the "Regulations on the Breeding and Management of Medical Experimental Animals in Sichuan Province" and the "Regulations on Experimental Animal Management of Sichuan University". (2) Title of the approved project: Preclinical study of mesenchymal stem cells. Full name of the institutional approval committee or unit: Medical Ethics Committee of Sichuan University, Chengdu, China. Approval number: No. K2018109-2. Date of approval: 24.12.2018.
: Not applicable.
: The authors declare no competing interests.
